Amneal Receives U.S. FDA Approval for Bimatoprost Ophthalmic Solution, 0.01%
Go back to Amneal Receives U.S. FDA Approval for Bimatoprost Ophthalmic Solution, 0.01%| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 17.68 +0.21 (1.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.47 | 52 Week High | $0.19 | |||
| Open | $17.57 | 52 Week Low | $0.07 | |||
| Day High | $17.99 | P/E | N/A | |||
| Day Low | $17.40 | EPS | $-0.01 | |||
| Volume | 1,364,822 | |||||
